Sarit Assouline Selected Research

Sarit Assouline Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 02/2006
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 06/2015
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 07/2009
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 06/2006
9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 09/2011
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 05/2019
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 01/2014
6	Neutropenia 12/2023 - 06/2015
6	Lymphoma (Lymphomas) 01/2022 - 02/2006
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 08/2008
4	Hodgkin Disease (Hodgkin's Disease) 01/2024 - 01/2014
4	Leukemia 12/2023 - 08/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2018
3	Philadelphia Chromosome 12/2023 - 02/2013
3	Gaucher Disease (Gaucher's Disease) 01/2021 - 02/2015
3	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 03/2011
2	Disease Progression 11/2023 - 05/2019
2	Hyperglycemia 01/2020 - 01/2018
2	Febrile Neutropenia 03/2018 - 06/2015
1	Blast Crisis (Blast Phase) 11/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Cytopenia 01/2022
1	Residual Neoplasm 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2020
1	Hepatitis B 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Hepatitis 01/2020
1	Hypertension (High Blood Pressure) 01/2020

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 09/2023 - 06/2015
9	Imatinib Mesylate (Gleevec)FDA Link 11/2020 - 06/2006
7	venetoclaxIBA 02/2024 - 01/2018
7	polatuzumab vedotinIBA 12/2023 - 06/2015
6	Tyrosine Kinase InhibitorsIBA 12/2023 - 07/2014
5	Bendamustine Hydrochloride FDA Link 09/2023 - 03/2018
5	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2014
3	Ribavirin (Virazole)FDA LinkGeneric 11/2023 - 07/2009
3	RG7388IBA 01/2023 - 01/2016
3	eliglustatIBA 01/2021 - 02/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2015
3	LipidsIBA 01/2021 - 02/2008
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2015
3	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2019 - 01/2018
2	Decitabine FDA Link 02/2024 - 11/2023
2	bosutinibIBA 12/2023 - 07/2014
2	AnthracyclinesIBA 12/2023 - 01/2021
2	EnzymesIBA 11/2023 - 07/2014
2	Peptide Initiation Factors (Initiation Factor)IBA 11/2023 - 07/2009
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 11/2023 - 07/2014
2	obinutuzumabIBA 09/2023 - 01/2020
2	NivolumabIBA 01/2023 - 01/2019
2	sphingosyl beta-glucosideIBA 01/2021 - 11/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 06/2015
2	tazemetostatIBA 01/2021 - 11/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 02/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 02/2006
2	Chlorambucil (Leukeran)FDA Link 01/2020 - 09/2011
2	Monoclonal AntibodiesIBA 01/2020 - 01/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2018
2	Syk KinaseIBA 01/2019 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2018
2	Lipase (Acid Lipase)FDA Link 01/2019 - 01/2016
2	BilirubinIBA 01/2019 - 01/2018
2	CreatinineIBA 01/2019 - 01/2018
2	ponatinibIBA 01/2016 - 01/2016
2	Eukaryotic Initiation Factor-4EIBA 01/2015 - 07/2009
1	Bispecific AntibodiesIBA 03/2024
1	cedazuridineIBA 02/2024
1	ChemokinesIBA 01/2024
1	cobimetinibIBA 01/2024
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2023
1	UGT1A1 enzymeIBA 12/2023
1	HhAntag691IBA 11/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	VaccinesIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Histone MethyltransferasesIBA 01/2021
1	DCLL9718SIBA 01/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2021
1	Glucosylceramides (Glucocerebrosides)IBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2021
1	chitotriosidaseIBA 01/2021
1	RO6839921IBA 10/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	idelalisibIBA 01/2020
1	NVP-BKM120IBA 01/2020
1	duvelisibIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	copanlisibIBA 01/2020

Therapy/Procedure

35	Therapeutics 02/2024 - 06/2006
9	Drug Therapy (Chemotherapy) 01/2024 - 02/2006
2	Immunotherapy 07/2023 - 01/2013
1	Aftercare (After-Treatment) 11/2023
1	Transplantation 10/2020